SCHEMBL8882142

SCHEMBL8882142

Cn1nccc1NC=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22303490 0.79
SCHEMBL13912546 0.75 MEN1 (0.37)
SCHEMBL49946 0.73 KMT2A (0.57)
SCHEMBL20413723 0.73 KMT2A (0.39)
SCHEMBL309844 0.73
SCHEMBL28308957 0.72 L3MBTL1 (0.31)
SCHEMBL8882941 0.72 MAPK1 (0.33)
SCHEMBL27691810 0.72 MAPK1 (0.30)
SCHEMBL5496667 0.72 MAPK1 (0.30)
SCHEMBL18861931 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116437915-B Crystal form of pyrrolo-heterocyclic derivative and preparation method thereof 江苏恒瑞医药股份有限公司 2025-03-18 CN disclosed
CN-118871442-A Crystal form of fumarate of pyrrolo-heterocyclic derivative and preparation method thereof 江苏恒瑞医药股份有限公司 2024-10-29 CN disclosed
CN-113518779-B Thieno heterocyclic derivative, preparation method and medical application thereof 江苏恒瑞医药股份有限公司 2024-03-15 CN disclosed
CN-113544131-B Pyrrolo-heterocyclic derivative, preparation method and medical application thereof 江苏恒瑞医药股份有限公司 2024-03-15 CN disclosed
CN-113825757-B Substituted fused bicyclic derivatives, preparation method thereof and application thereof in medicine 江苏恒瑞医药股份有限公司 2023-10-20 CN disclosed
US-20230331731-A1 CRYSTAL FORM OF PYRROLO HETEROCYCLIC DERIVATIVE AND PREPARATION METHOD THEREFOR JIANGSU HENGRUI PHARMACEUTICALS CO., LTD. (CN) 2023-10-19 US disclosed
WO-2023185869-A1 CRYSTALLINE FORM OF FUMARATE OF PYRROLOHETEROCYCLIC DERIVATIVE AND PREPARATION METHOD THEREFOR 江苏恒瑞医药股份有限公司 2023-10-05 WO disclosed
EP-4223758-A1 CRYSTAL FORM OF PYRROLO HETEROCYCLIC DERIVATIVE AND PREPARATION METHOD THEREFOR Jiangsu Hengrui Pharmaceuticals Co., Ltd. (CN) 2023-08-09 EP disclosed
CN-116437915-A Crystal form of pyrrolo-heterocyclic derivative and preparation method thereof 江苏恒瑞医药股份有限公司 2023-07-14 CN disclosed
CN-114315837-B Crystalline forms of ERK inhibitors and methods of making the same 江苏恒瑞医药股份有限公司 2023-06-16 CN disclosed
US-5194432-A Drugs for treatment of infectious diseases; microbiocides FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1993-03-16 US disclosed
US-5162520-A Useful in the preparation of antimicrobial compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-11-10 US disclosed
US-5108997-A Microbiocides FUJISAWA PHARMACEUTICALS CO., LTD. (JP) 1992-04-28 US disclosed
US-4960766-A SUBSTITUTED 2-PYRAZOLIOMETHYL GROUP AND A 7-(AMINOTHIAZOLYL) (ALKOXYIMINO)-ACETAMIDO GROUP CEPHALOSPORIN DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1990-10-02 US disclosed
US-4927818-A ANTIBIOTICS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1990-05-22 US disclosed
EP-0306863-A2 Cephem compounds and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-03-15 EP disclosed
CN-87106452-A New cephalosporanic olefinic compound and preparation method thereof 1988-05-04 CN disclosed
EP-0261615-A2 Cephem compounds, processes for preparation thereof and pharmaceutical compositions comprising them FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-03-30 EP disclosed
EP-0223246-A2 New cephem compounds and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1987-05-27 EP disclosed
CN-86107947-A New cephem compounds and preparation method thereof 1987-05-27 CN disclosed